Stay updated with breaking news from Quantamatrix Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Antibiotic Susceptibility Testing Market generated US$2.82 billion in sales in 2021. By 2028, the global market is projected to have grown at a CAGR of 5.2% and be worth US$ 4.05 billion.A recently published research intelligence on the global antibiotic susceptibility testing market share by Future Market Insig...
QuantaMatrix, an in vitro diagnostics company specializing in the discovery, development and commercialization of fully integrated solutions within the sepsis value chain, today announces that its dRAST™ solution has been adopted for routine clinical use by admed, a Swiss-based laboratory.
/PRNewswire/ -- QuantaMatrix, an in vitro diagnostics company specializing in the discovery, development and commercialization of fully-integrated solutions...
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Antimicrobial Susceptibility Testing Market worth $4.2 billion by 2025 – Size, Industry Trends, Key Players and Forecast